Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 31 Mar 2008 |
| Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility | 13 Mar 2008 |
| Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets | 3 Mar 2008 |
| Genmab to Attend Two March Investor Conferences | 27 Feb 2008 |
| Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance | 26 Feb 2008 |